环码生物宣布与辉瑞达成研发合作协议，共同探索环形RNA疗法的潜力

中国上海——环码生物宣布与辉瑞达成研发合作协议，双方将共同探索环形RNA疗法的潜力。

本次合作将充分发挥环码生物独有的环形RNA技术平台，结合辉瑞在制药行业的广泛专长及经验，双方携手深化对环形RNA技术的理解，共同促进环形RNA技术转化为药物候选分子。

CirCode Announces Research Agreement with Pfizer to Explore the Potential of Circular RNA Therapeutics

Shanghai, China – CirCode Biomed announced a research agreement with Pfizer Inc. to explore the potential of CirCode’s Circular RNA therapeutics technology.   The aim of the agreement is to deepen current knowledge of how to translate circular RNA technology into potential drug candidates and will make use of CirCode’s proprietary circular RNA platform and Pfizer’s broad expertise in drug discovery.